Tokyo Tape
Sign in
← Terumo

Half-year report · Q2

4543.TEDINET S100UOKT
Period2024-04-01 → 2024-09-30
Filed2024-11-11
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥508.7bn2024-04-01 → 2024-09-30Cons.Revenue IFRS
Revenue¥921.9bn2023-04-01 → 2024-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥443.9bn2023-04-01 → 2023-09-30Cons.Revenue IFRS
Operating income¥87.7bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Operating income¥66.5bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Profit before tax¥85.1bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Profit before tax¥140.8bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥66.4bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥63.2bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥106.4bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥50.1bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥63.2bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Net income¥50.1bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Total assets¥1.75Tat 2024-09-30Cons.Assets IFRS
Total assets¥1.83Tat 2024-03-31Cons.Assets IFRS
Total assets¥1.75Tat 2023-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥438.8bnat 2024-09-30Cons.Liabilities IFRS
Total liabilities¥504.3bnat 2024-03-31Cons.Liabilities IFRS
Net assets / equity¥1.31Tat 2024-09-30Cons.Equity IFRS
Net assets / equity¥1.33Tat 2024-03-31Cons.Equity IFRS
Net assets / equity¥1.26Tat 2023-09-30Cons.Equity IFRS
Net assets / equity¥1.11Tat 2023-03-31dCons.Equity IFRS
Equity (owners)¥1.31Tat 2024-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.33Tat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.26Tat 2023-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥194.9bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥204.9bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥187.3bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥187.3bnat 2023-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥100.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥146.3bn2023-04-01 → 2024-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥53.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥38.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥81.5bn2023-04-01 → 2024-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥36.1bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥65.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥62.1bn2023-04-01 → 2024-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥30.0bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥42.572024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥71.52023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥33.632023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥42.562024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥71.472023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥33.622023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio75.0%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio72.5%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio72.1%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue external2024-04-01 → 2024-09-30¥132m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30¥1.2bn
jpcrp040300-q2r_E01630-000Blood And Cell Technologies Companyreportable segmentrevenue external2024-04-01 → 2024-09-30¥98.0bn
jpcrp040300-q2r_E01630-000Blood And Cell Technologies Companyreportable segmentsegment profit2024-04-01 → 2024-09-30¥13.2bn
jpcrp040300-q2r_E01630-000Cardiac And Vascular Companyreportable segmentrevenue external2024-04-01 → 2024-09-30¥306.3bn
jpcrp040300-q2r_E01630-000Cardiac And Vascular Companyreportable segmentsegment profit2024-04-01 → 2024-09-30¥76.9bn
jpcrp040300-q2r_E01630-000Medical Care Solutions Companyreportable segmentrevenue external2024-04-01 → 2024-09-30¥104.3bn
jpcrp040300-q2r_E01630-000Medical Care Solutions Companyreportable segmentsegment profit2024-04-01 → 2024-09-30¥12.7bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥508.6bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥102.8bn
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-09-30¥119m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥1.0bn
jpcrp040300-q2r_E01630-000Blood And Cell Technologies Companyreportable segmentrevenue external2023-04-01 → 2023-09-30¥84.1bn
jpcrp040300-q2r_E01630-000Blood And Cell Technologies Companyreportable segmentsegment profit2023-04-01 → 2023-09-30¥10.6bn
jpcrp040300-q2r_E01630-000Cardiac And Vascular Companyreportable segmentrevenue external2023-04-01 → 2023-09-30¥265.7bn
jpcrp040300-q2r_E01630-000Cardiac And Vascular Companyreportable segmentsegment profit2023-04-01 → 2023-09-30¥57.6bn
jpcrp040300-q2r_E01630-000Medical Care Solutions Companyreportable segmentrevenue external2023-04-01 → 2023-09-30¥94.0bn
jpcrp040300-q2r_E01630-000Medical Care Solutions Companyreportable segmentsegment profit2023-04-01 → 2023-09-30¥8.3bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥443.8bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥76.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 637
ItemContextValueUnit
Equity IFRSPrior1QuarterInstant_ShareCapitalIFRSMember38716000000JPY
Equity IFRSPrior1QuarterInstant_CapitalSurplusIFRSMember51631000000JPY
Equity IFRSPrior1QuarterInstant_TreasurySharesIFRSMember-11182000000JPY
Equity IFRSPrior1QuarterInstant_RetainedEarningsIFRSMember908810000000JPY
Equity IFRSPrior1QuarterInstant_OtherComponentsOfEquityIFRSMember273019000000JPY
Equity IFRSPrior1QuarterInstant_EquityAttributableToOwnersOfParentIFRSMember1260996000000JPY
Equity IFRSPrior1QuarterInstant1260996000000JPY
Equity IFRSPrior1YearInstant_ShareCapitalIFRSMember38716000000JPY
Equity IFRSPrior1YearInstant_CapitalSurplusIFRSMember51752000000JPY
Equity IFRSPrior1YearInstant_TreasurySharesIFRSMember-12436000000JPY
Equity IFRSPrior1YearInstant_RetainedEarningsIFRSMember954679000000JPY
Equity IFRSPrior1YearInstant_OtherComponentsOfEquityIFRSMember294379000000JPY
Equity IFRSPrior1YearInstant_EquityAttributableToOwnersOfParentIFRSMember1327090000000JPY
Equity IFRSPrior1YearInstant1327090000000JPY
Profit loss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Profit loss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Profit loss IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Profit loss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember63204000000JPY
Profit loss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember63204000000JPY
Profit loss IFRSCurrentYTDDuration63204000000JPY
Other comprehensive income IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Other comprehensive income IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Other comprehensive income IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Other comprehensive income IFRSCurrentYTDDuration_RetainedEarningsIFRSMember－JPY
Other comprehensive income IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-58363000000JPY
Other comprehensive income IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-58363000000JPY
Other comprehensive income IFRSCurrentYTDDuration-58363000000JPY
Comprehensive income IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSCurrentYTDDuration_RetainedEarningsIFRSMember63204000000JPY
Comprehensive income IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-58363000000JPY
Comprehensive income IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember4840000000JPY
Comprehensive income IFRSCurrentYTDDuration4840000000JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember-1000000JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember-2246000000JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-2247000000JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration-2247000000JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember-179000000JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember406000000JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember－JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-226000000JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember0JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration0JPY
Dividends ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass